Back to Selection     Print       Date : 31 Oct 2025
Fund Summary
Invesco India Contra Fund (G)
[Equity: Contra]  
 
Fund Details
Fund Type Growth Launch Date 11-Apr-07
Corpus(Cr.) 20173.0 Latest NAV 138.63 As on 05-12-2025
Equity(%) 98.73 52 Week High 139.06
Debt(%) 1.27 52 Week Low 115.75
Others(%) 0.0 Exit Load For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.63
Scheme Benchmark BSE 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Amit Ganatra
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate capital appreciation by investing predominantly in Equity and Equity Related Instruments through contrarian investing.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 25.64%
Top 10 Holdings 39.71%
Top 25 Holdings 64.17%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 24.37
Retail 9.45
Software & Services 9.43
Pharma & Biotech 7.59
Automobile 7.44
Construction 5.44
Industrial Products 4.88
Finance & Investments 4.54
Healthcare 3.97
Consumer Durables 3.11
Petroleum Products 3.03
Derivatives 2.76
Miscellaneous 2.09
Telecom 2.04
Aerospace & Defence 1.86
Food Beverage & Tobacco 1.6
Transportation 1.36
SERVICES 1.19
Cash 1.02
Paper 0.9
Electricals 0.83
FMCG 0.47
Chemicals 0.36
Debt MF 0.25
Preference Shares 0.02
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.14
PE Ratio 28.92
 
Top 25 Holdings
Holdings Net Asset(%)
HDFC Bank Limited 7.29
ICICI Bank Limited 6.05
Infosys Limited 4.66
Mahindra & Mahindra Limited 3.84
Larsen & Toubro Limited 3.80
Axis Bank Limited 3.18
Triparty Repo 2.92
Eternal Limited 2.81
Apollo Hospitals Enterprise Limited 2.71
Cholamandalam Invest & Finance Co Ltd 2.45
Coforge Limited 2.20
Bharti Airtel Limited 2.04
Bharat Electronics Limited 1.86
Prestige Estates Projects Limited 1.73
Kotak Mahindra Bank Limited 1.71
Federal Bank Limited 1.70
Glenmark Pharmaceuticals Limited 1.56
Larsen & Toubro Infotech Ltd 1.54
Reliance Industries Limited 1.52
TVS Motor Co Ltd 1.52
Hindustan Petroleum Corp. Ltd. 1.51
KEI INDUSTRIES LTD 1.45
Avenue Supermarts Limited 1.43
FSN E COMMERCE VENTURES LTD 1.39
Mankind Pharma Limited 1.30

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
1.71% 3.14% 2.92% 0.17%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.70% 6.00% 5.46% 7.43%
 
Scheme Benchmark [NSE - Nifty 500 TRI]
1.42% 4.55% 3.51% 3.28%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
18.43% 18.92% 19.35% 16.40%
 
 
13.19% 13.29% 15.94% 14.28%
 
 
14.06% 15.48% 17.95% 14.98%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Invesco India Contra Fund (G) 13.48% 0.8030 11.6063% 41.4073 0.1163
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Invesco India Contra Fund (G) 5.8686% 0.0004 0.1281 6.6489 1.1666
 
Back to Selection